blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2109605

EP2109605 - 2- [(PHENYLAMINO) -PYRIMIDIN-4YLAMIN0] -CYCLOPENTANE CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF KINASES OF THE CELL CYCLE FOR THE TREATMENT OF CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.12.2013
Database last updated on 02.11.2024
Most recent event   Tooltip04.09.2015Lapse of the patent in a contracting state
New state(s): MT		published on 07.10.2015  [2015/41]
Applicant(s)For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2013/08]For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Former [2009/43]For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Inventor(s)01 / ZAHN, Stephan
Speisinger Strasse 113/10
1130 Vienna / AT
02 / BOEHMELT, Guido
Ebenfeldweg 11
2531 Gaaden / AT
03 / GUERTLER, Ulrich
Bischoffgasse 14
1120 Vienna / AT
04 / MANTOULIDIS, Andreas
Otto Bondy Platz 4
Haus D1, Top 001
1120 Vienna / AT
05 / SCHOOP, Andreas
Am Schwaigfeld 17
82061 Neuried / DE
06 / SOLCA, Flavio
Gesslgasse 10/6
1230 Vienna / AT
07 / TONTSCH-GRUNT, Ulrike
Oetkerweg 23
2500 Baden / AT
08 / TREU, Matthias
Sedlitzkygasse 5/5
1110 Vienna / AT
 [2013/08]
Former [2009/43]01 / ZAHN, Stephan
Speisinger Strasse 113/10
1130 Vienna / AT
02 / BOEHMELT, Guido
Ebenfeldweg 11
2531 Gaaden / AT
03 / GUERTLER, Ulrich
Bischoffgasse 14
1120 Vienna / AT
04 / MANTOULIDIS, Andreas
Otto Bondy Platz 4 Haus D1, Top 001
1120 Vienna / AT
05 / SCHOOP, Andreas
Am Schwaigfeld 17
82061 Neuried / DE
06 / SOLCA, Flavio
Gesslgasse 10/6
1230 Vienna / AT
07 / TONTSCH-GRUNT, Ulrike
Oetkerweg 23
2500 Baden / AT
08 / TREU, Matthias
Sedlitzkygasse 5/5
1110 Vienna / AT
Representative(s)Simon, Elke Anna Maria, et al
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2012/40]
Former [2009/48]Hammann, Heinz
Boehringer Ingelheim GmbH CD-Patents Binger Strasse 173
55216 Ingelheim am Rhein / DE
Former [2009/43]Hammann, Heinz
Boehringer Ingelheim GmbH CD Patents Binger Strasse 173
D-55216 Ingelheim Am Rhein / DE
Application number, filing date07866297.020.12.2007
[2009/43]
WO2007EP64342
Priority number, dateEP2006012704322.12.2006         Original published format: EP 06127043
[2009/43]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008077885
Date:03.07.2008
Language:EN
[2008/27]
Type: A2 Application without search report 
No.:EP2109605
Date:21.10.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 03.07.2008 takes the place of the publication of the European patent application.
[2009/43]
Type: B1 Patent specification 
No.:EP2109605
Date:20.02.2013
Language:EN
[2013/08]
Search report(s)International search report - published on:EP14.08.2008
ClassificationIPC:C07D239/48, A61K31/505, A61P35/00
[2009/43]
CPC:
C07D239/48 (EP,US); A61P29/00 (EP); A61P31/00 (EP);
A61P35/00 (EP); A61P37/02 (EP); A61P43/00 (EP);
C07D401/12 (EP,US); C07D401/14 (EP,US); C07D403/12 (EP,US);
C07D405/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/43]
TitleGerman:2-[(PHENYLAMIN)-PYRIMIDIN-4YL-AMINO]-CYCLOPENTAN-CARBOXAMID-DERIVATE UND ENTSPRECHENDE VERBINDUNGEN ALS ZELLZYKLENKINASEHEMMER ZUR KREBSBEHANDLUNG[2009/43]
English:2- [(PHENYLAMINO) -PYRIMIDIN-4YLAMIN0] -CYCLOPENTANE CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF KINASES OF THE CELL CYCLE FOR THE TREATMENT OF CANCER[2009/43]
French:DERIVÉS 2-[(PHÉNYLAMINO)-PYRIMIDIN-4YL-AMIN0]-CYCLOPENTANE CARBOXAMIDE ET COMPOSÉS SIMILAIRES EN TANT QUE INHIBITEURS DES KINASES DU CYCLE CELLURAIRE POUR LE TRAITEMENT DU CANCER[2009/43]
Entry into regional phase22.07.2009National basic fee paid 
22.07.2009Designation fee(s) paid 
22.07.2009Examination fee paid 
Examination procedure22.07.2009Examination requested  [2009/43]
08.01.2010Despatch of a communication from the examining division (Time limit: M04)
14.06.2010Reply to a communication from the examining division
22.12.2011Despatch of a communication from the examining division (Time limit: M06)
02.07.2012Reply to a communication from the examining division
02.08.2012Communication of intention to grant the patent
30.11.2012Fee for grant paid
30.11.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.01.2010
Opposition(s)21.11.2013No opposition filed within time limit [2014/05]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
14.06.2010Request for further processing filed
14.06.2010Full payment received (date of receipt of payment)
Fees paidRenewal fee
04.01.2010Renewal fee patent year 03
03.01.2011Renewal fee patent year 04
02.01.2012Renewal fee patent year 05
02.01.2013Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.12.2007
AT20.02.2013
BE20.02.2013
CY20.02.2013
CZ20.02.2013
DK20.02.2013
EE20.02.2013
FI20.02.2013
IT20.02.2013
LT20.02.2013
LV20.02.2013
MC20.02.2013
MT20.02.2013
NL20.02.2013
PL20.02.2013
RO20.02.2013
SE20.02.2013
SI20.02.2013
SK20.02.2013
TR20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
PT20.06.2013
[2015/41]
Former [2015/34]HU20.12.2007
AT20.02.2013
BE20.02.2013
CY20.02.2013
CZ20.02.2013
DK20.02.2013
EE20.02.2013
FI20.02.2013
IT20.02.2013
LT20.02.2013
LV20.02.2013
MC20.02.2013
NL20.02.2013
PL20.02.2013
RO20.02.2013
SE20.02.2013
SI20.02.2013
SK20.02.2013
TR20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
PT20.06.2013
Former [2015/32]AT20.02.2013
BE20.02.2013
CY20.02.2013
CZ20.02.2013
DK20.02.2013
EE20.02.2013
FI20.02.2013
IT20.02.2013
LT20.02.2013
LV20.02.2013
MC20.02.2013
NL20.02.2013
PL20.02.2013
RO20.02.2013
SE20.02.2013
SI20.02.2013
SK20.02.2013
TR20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
PT20.06.2013
Former [2014/38]AT20.02.2013
BE20.02.2013
CY20.02.2013
CZ20.02.2013
DK20.02.2013
EE20.02.2013
FI20.02.2013
IT20.02.2013
LT20.02.2013
LV20.02.2013
MC20.02.2013
NL20.02.2013
PL20.02.2013
RO20.02.2013
SE20.02.2013
SI20.02.2013
SK20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
PT20.06.2013
Former [2014/03]AT20.02.2013
BE20.02.2013
CY20.02.2013
CZ20.02.2013
DK20.02.2013
EE20.02.2013
FI20.02.2013
IT20.02.2013
LT20.02.2013
LV20.02.2013
NL20.02.2013
PL20.02.2013
RO20.02.2013
SE20.02.2013
SI20.02.2013
SK20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
PT20.06.2013
Former [2013/52]AT20.02.2013
BE20.02.2013
CY20.02.2013
CZ20.02.2013
DK20.02.2013
EE20.02.2013
FI20.02.2013
LT20.02.2013
LV20.02.2013
NL20.02.2013
PL20.02.2013
RO20.02.2013
SE20.02.2013
SI20.02.2013
SK20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
PT20.06.2013
Former [2013/49]AT20.02.2013
BE20.02.2013
CZ20.02.2013
DK20.02.2013
EE20.02.2013
FI20.02.2013
LT20.02.2013
LV20.02.2013
NL20.02.2013
PL20.02.2013
RO20.02.2013
SE20.02.2013
SI20.02.2013
SK20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
PT20.06.2013
Former [2013/48]AT20.02.2013
BE20.02.2013
DK20.02.2013
EE20.02.2013
FI20.02.2013
LT20.02.2013
LV20.02.2013
NL20.02.2013
PL20.02.2013
SE20.02.2013
SI20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
PT20.06.2013
Former [2013/40]AT20.02.2013
BE20.02.2013
FI20.02.2013
LT20.02.2013
LV20.02.2013
PL20.02.2013
SE20.02.2013
SI20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
PT20.06.2013
Former [2013/38]AT20.02.2013
BE20.02.2013
FI20.02.2013
LT20.02.2013
LV20.02.2013
PL20.02.2013
SE20.02.2013
SI20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
Former [2013/37]AT20.02.2013
FI20.02.2013
LT20.02.2013
PL20.02.2013
SE20.02.2013
SI20.02.2013
BG20.05.2013
GR21.05.2013
ES31.05.2013
IS20.06.2013
Former [2013/36]AT20.02.2013
LT20.02.2013
PL20.02.2013
SE20.02.2013
BG20.05.2013
ES31.05.2013
IS20.06.2013
Former [2013/34]LT20.02.2013
SE20.02.2013
BG20.05.2013
IS20.06.2013
Former [2013/33]LT20.02.2013
Cited inInternational search[X]WO2005063722  (RIGEL PHARMACEUTICALS INC [US], et al) [X] 1-9 * page 6, line 1 - line 10 * * page 29, line 23 - page 30, line 11 * * examples 1-6 * * claim - *;
 [X]WO2005118544  (RIGEL PHARMACEUTICALS INC [US], et al) [X] 1-9 * page 10, line 10 - page 11, line 27 * * page 49, line 8 - page 51, line 32 * * page 79, line 7 - line 13 * * compounds 15A-D, * * compounds 102, 106, 107, 158, 159, 194-218 * * compounds 222, 278-283, 286, 287 * * page 145 - page 149 * * claim - *;
 [PX]WO2007003596  (BOEHRINGER INGELHEIM INT [DE], et al) [PX] 1-9 * page 5, line 20 - line 30 * * page 83, line 4 - page 89, line 14 * * example - * * claim - *;
 [PX]WO2007027238  (RIGEL PHARMACEUTICALS INC [US], et al) [PX] 1-9 * page 1, paragraph 1 * * page 3, paragraph 10 - page 7, paragraph 22 * * compounds 2,87 * * claim - *
by applicantWO02096888
 WO03032997
 WO2005063722
 WO2005118544
 WO2007003596
 WO2007027238
    - FORRO, E.; FUELOEP, F., "Lipase-Catalyzed Enantioselective Ring Opening of Unactivated Alicyclic-Fused (3-Lactams in an Organic Solvent", ORG. LETT, (2003), vol. 5, doi:doi:10.1021/ol034096o, pages 1209 - 1212, XP002501041

DOI:   http://dx.doi.org/10.1021/ol034096o
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.